China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
28.71
-0.07 (-0.24%)
Mar 26, 2026, 3:00 PM CST

SHA:600511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,48210,88610,9268,8967,304
Trading Asset Securities
----11.4
Cash & Short-Term Investments
11,48210,88610,9268,8967,316
Cash Growth
5.47%-0.36%22.81%21.60%17.53%
Accounts Receivable
14,74313,93112,88112,55013,392
Other Receivables
359.33199.01204389.6979.93
Receivables
15,10214,13013,08512,94013,472
Inventory
5,1924,9563,9613,7173,515
Other Current Assets
215.33385.73307.79210.44280.62
Total Current Assets
31,99130,35728,27925,76424,584
Property, Plant & Equipment
778.96878.6827.04857.91845.06
Long-Term Investments
2,4652,1761,9071,6231,365
Goodwill
203.77203.77203.77203.77203.77
Other Intangible Assets
243.1276.76258.11262.92258.65
Long-Term Deferred Tax Assets
163.25149.07123.87124.37115.94
Long-Term Deferred Charges
148.78152.39150.0686.1989.6
Other Long-Term Assets
690.6734.85703.57686.95548.08
Total Assets
36,68534,92832,45329,60928,010
Accounts Payable
12,78512,08610,9439,91710,058
Accrued Expenses
145.17536.83604.96640.01564.03
Short-Term Debt
222.31485.06268.35252.06428.83
Current Portion of Long-Term Debt
102.11----
Current Portion of Leases
-100.274.0880.575.81
Current Income Taxes Payable
163.8387.49113.1784.89112.18
Current Unearned Revenue
67.88275.2561.12176.943.68
Other Current Liabilities
1,9161,2851,8301,5891,457
Total Current Liabilities
15,40214,85613,89412,74012,739
Long-Term Leases
191.86260.69205.08182.57197.29
Long-Term Unearned Revenue
34.1838.7946.0646.3542.66
Pension & Post-Retirement Benefits
-0.270.440.450.54
Long-Term Deferred Tax Liabilities
17.824.1926.7833.4735.39
Other Long-Term Liabilities
730.82773.55747.14747.14639.8
Total Liabilities
16,37715,95314,92013,75013,655
Common Stock
754.5754.5754.5754.5754.5
Additional Paid-In Capital
2,3492,3492,3492,3492,349
Retained Earnings
15,39013,99712,64211,0879,652
Comprehensive Income & Other
50.9227.2830.7424.0424.91
Total Common Equity
18,54517,12815,77614,21512,780
Minority Interest
1,7641,8471,7571,6451,575
Shareholders' Equity
20,30818,97517,53315,85914,355
Total Liabilities & Equity
36,68534,92832,45329,60928,010
Total Debt
516.28845.95547.5515.13701.93
Net Cash (Debt)
10,96510,04010,3788,3816,614
Net Cash Growth
9.22%-3.26%23.83%26.72%21.97%
Net Cash Per Share
14.5313.3113.7611.118.77
Filing Date Shares Outstanding
754.53754.5754.5754.5754.5
Total Common Shares Outstanding
754.53754.5754.5754.5754.5
Working Capital
16,58915,50114,38513,02511,845
Book Value Per Share
24.5822.7020.9118.8416.94
Tangible Book Value
18,09816,64815,31413,74812,318
Tangible Book Value Per Share
23.9922.0620.3018.2216.33
Buildings
-408.84408.84433.49387.18
Machinery
-802.66759.8702.78661.15
Construction In Progress
-0.572.5436.2157.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.